- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Certolizumab pegol – November 2014
Certolizumab pegol; 200 mg/mL injection, 2 x 1 mL syringes; Cimzia®
Last updated
6 March 2015